{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:08:37Z","timestamp":1789826917981,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2021-JYB-XJSJJ-003"],"award-info":[{"award-number":["2021-JYB-XJSJJ-003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2016-I2M-1\u2013011"],"award-info":[{"award-number":["2016-I2M-1\u2013011"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011636","name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines","doi-asserted-by":"publisher","award":["GTZK202108"],"award-info":[{"award-number":["GTZK202108"]}],"id":[{"id":"10.13039\/501100011636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejphar.2022.175436","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:22:16Z","timestamp":1670253736000},"page":"175436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice"],"prefix":"10.1016","volume":"938","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9936-1185","authenticated-orcid":false,"given":"Can","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshuang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175436_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105858","article-title":"Thymol-enriched extract from Thymus vulgaris L leaves: green extraction processes and antiaggregant effects on human platelets","volume":"125","author":"Adhar","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejphar.2022.175436_bib2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.5551\/jat.RV17022","article-title":"Thrombus formation and propagation in the onset of cardiovascular events","volume":"25","author":"Asada","year":"2018","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.ejphar.2022.175436_bib3","first-page":"401","article-title":"Studies on the hypoglycemic effect of Coptis chinensis and berberine","volume":"21","author":"Chen","year":"1986","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejphar.2022.175436_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105540","article-title":"Anti-thrombotic effects mediated by dihydromyricetin involve both platelet inhibition and endothelial protection","volume":"167","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2022.175436_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.2019004234","article-title":"A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle","volume":"136","author":"Chen","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2022.175436_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109889","article-title":"3,5,2',4'-Tetramethoxystilbene, a fully methylated resveratrol analog, prevents platelet aggregation and thrombus formation by targeting the protease-activated receptor 4 pathway","volume":"357","author":"Chiang","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2022.175436_bib7","first-page":"323","volume":"vol. 10","author":"Chu","year":"1989"},{"key":"10.1016\/j.ejphar.2022.175436_bib8","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.21037\/jtd.2018.03.95","article-title":"Recent progress and market analysis of anticoagulant drugs","volume":"10","author":"Fan","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejphar.2022.175436_bib9","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1021\/acs.jmedchem.2c00592","article-title":"Palmatine derivatives as potential antiplatelet aggregation agents via protein kinase G\/Vasodilator-Stimulated phosphoprotein and phosphatidylinositol 3-kinase\/akt phosphorylation","volume":"65","author":"Fan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2022.175436_bib10","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.3389\/fphar.2018.00214","article-title":"Gut microbiota-regulated pharmacokinetics of berberine and active metabolites in beagle dogs after oral administration","volume":"9","author":"Feng","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175436_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114784","article-title":"Integrating network pharmacology and non-targeted metabolomics to explore the common mechanism of Coptis Categorized Formula improving T2DM zebrafish","volume":"284","author":"He","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2022.175436_bib12","first-page":"228","article-title":"The clinical and basic study on the antiplatelet aggregation effect of berberine","volume":"10","author":"Huang","year":"1989","journal-title":"Chin. J. Hematol."},{"key":"10.1016\/j.ejphar.2022.175436_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107496","article-title":"Berberine in the treatment of metabolism-related chronic diseases: a drug cloud (dCloud) effect to target multifactorial disorders","volume":"209","author":"Kong","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175436_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cca.2022.06.022","article-title":"Serum metabolomics study of anxiety disorder patients based on LC-MS","volume":"533","author":"Kui","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2022.175436_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.phrs.2019.04.013","article-title":"LongShengZhi Capsule reduces carrageenan-induced thrombosis by reducing activation of platelets and endothelial cells","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2022.175436_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114035","article-title":"Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs","volume":"228","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2022.175436_bib17","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1016\/j.bmc.2010.06.106","article-title":"Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine","volume":"18","author":"Li","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2022.175436_bib18","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1186\/1479-5876-9-62","article-title":"Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes","volume":"9","author":"Li","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2022.175436_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115152","article-title":"Discovery of 7, 4'-dimethoxy-3-hydroxyflavone as a protease-activated receptor 4 antagonist with antithrombotic activity and less bleeding tendency in mice","volume":"202","author":"Lin","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175436_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc5667","article-title":"Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation","volume":"371","author":"Liu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2022.175436_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01027-6","article-title":"Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2022.175436_bib22","unstructured":"Maestro platform, Schr\u04e7dinger LLC."},{"key":"10.1016\/j.ejphar.2022.175436_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","volume":"386","author":"Mega","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2022.175436_bib24","series-title":"National Pharmacopoeia Committee, Pharmacopoeia of People's Republic of China\/Part II","first-page":"1054","article-title":"Berberine hydrochloride and berberine hydrochloride tablets","year":"2020"},{"key":"10.1016\/j.ejphar.2022.175436_bib25","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2017.08.037","article-title":"Antiplatelet agents for the treatment and prevention of coronary atherothrombosis","volume":"70","author":"Patrono","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2022.175436_bib26","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2022.175436_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between platelets and coagulation","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.ejphar.2022.175436_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41401-018-0010-1","article-title":"Pharmacological actions of miltirone in the modulation of platelet function","volume":"40","author":"Song","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2022.175436_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.175436_bib30","unstructured":"The PyMOL Molecular Graphics System, Schr\u00f6dinger LLC."},{"key":"10.1016\/j.ejphar.2022.175436_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gheart.2018.09.511","article-title":"Global atlas of cardiovascular disease 2000-2016: the path to prevention and control","volume":"13","author":"Thomas","year":"2018","journal-title":"Global heart"},{"key":"10.1016\/j.ejphar.2022.175436_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejphar.2022.175436_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood.2018874214","article-title":"Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis","volume":"134","author":"Verma","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2022.175436_bib34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3923\/ijp.2018.1087.1098","article-title":"Evaluation of anticoagulant and antithrombotic activities of berberine: a focus on the ameliorative effect on blood hypercoagulation","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175436_bib35","article-title":"Berberine and its main metabolite berberrubine inhibit platelet activation through suppressing the class I PI3k\u03b2\/rasa3\/rap1 pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175436_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.metabol.2017.02.003","article-title":"Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism","volume":"70","author":"Wang","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2022.175436_bib37","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.7150\/thno.18290","article-title":"Gut microbiota-mediated personalized treatment of hyperlipidemia using berberine","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2022.175436_bib38","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1016\/j.bmc.2012.09.029","article-title":"Synthesis and structure-activity relationship of berberine analogues in LDLR up-regulation and AMPK activation","volume":"20","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2022.175436_bib39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jpha.2020.10.001","article-title":"Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota","volume":"11","author":"Zhang","year":"2021","journal-title":"J. Pharm. Anal."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922006975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922006975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:16:31Z","timestamp":1757978191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922006975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":39,"alternative-id":["S0014299922006975"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175436","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175436"}}